MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$3,331,189
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from exercise of warran...
Amortization of right-of-use ass...
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Net loss
Repayment of insurance premium f...
Deferred patent costs
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-3,347,660
-3,927,240
-2,233,504
-2,764,528
Depreciation and amortization
38,793
37,692
35,010
34,766
Gain/loss on lease modification
-3,915
2,163
2,332
838
Amortization of right-of-use assets
74,769
78,961
78,094
77,235
Change in foreign currency rates on remeasurement of canadian fixed assets
-
-
0
0
Stock based compensation
11,405
6,149
12,146
4,165
Change in fair value of warrant liability
0
0
-51
-133
Loss on issuance of common stock
-
-
0
0
Gain on disposal of property and equipment
0
0
0
-3,244
Impairment of intangible assets and deferred patent costs
0
623,532
0
0
Accounts receivable
-4,199
4,196
912
0
Prepaid expenses
16,636
-255,303
-2,210
-158,954
Other assets
-186
-174
163
-170
Tax credits receivable
-5,563
9,001
130,017
-68,041
Income tax payable/receivable
-
-
-11,898
5,642
Income tax payable
0
-6,256
-
-
Accounts payable and accrued expenses
15,159
542,064
-593,872
53,122
Operating lease liability
-72,999
-76,649
-75,782
-74,948
Net cash used in operating activities
-3,291,136
-2,477,304
-2,892,611
-2,444,716
Purchases of property and equipment
40,053
14,928
9,249
3,363
Proceeds from sale of property and equipment
0
0
0
0
Deferred patent costs
77,488
22,211
74,609
37,715
Net cash used in investing activities
-117,541
-37,139
-83,858
-41,078
Payment of deferred offering/issuance costs
-
-
286
0
Principal payments on finance leases
4,364
4,261
4,161
4,062
Proceeds from public offerings, net
0
0
1,698
-2,324
Proceeds from exercise of warrants
196,800
-
-
-
Proceeds from private placement, net
-6,491
10,384,194
1,342,329
-
Proceeds from equity line of credit
0
215,950
2,399,671
2,848,328
Repayment of insurance premium financing liability
100,463
98,520
96,577
-
Proceeds from exercise of stock options
-
-
0
0
Net cash provided by financing activities
85,482
10,497,363
3,642,674
2,841,942
Net change in cash and cash equivalents
-3,323,195
7,982,920
666,205
356,148
Cash and cash equivalents at beginning of period
10,051,003
2,068,083
1,401,878
4,554,719
Cash and cash equivalents at end of period
6,727,808
10,051,003
2,068,083
1,401,878
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from exercise of
warrants
$196,800
Net cash provided by
financing activities
$85,482
(-96.49%↓ Y/Y)
Canceled cashflow
$111,318
Net change in cash
and cash...
-$3,323,195
(5.29%↑ Y/Y)
Canceled cashflow
$85,482
Amortization of right-of-use
assets
$74,769
(-53.20%↓ Y/Y)
Depreciation and
amortization
$38,793
(-43.20%↓ Y/Y)
Accounts payable and
accrued expenses
$15,159
(-62.51%↓ Y/Y)
Stock based
compensation
$11,405
(-75.44%↓ Y/Y)
Tax credits
receivable
-$5,563
(76.08%↑ Y/Y)
Accounts receivable
-$4,199
(-1702.15%↓ Y/Y)
Other assets
-$186
(-139.74%↓ Y/Y)
Repayment of insurance
premium financing...
$100,463
Proceeds from private
placement, net
-$6,491
Principal payments on
finance leases
$4,364
(-44.32%↓ Y/Y)
Net cash used in
operating activities
-$3,291,136
(44.09%↑ Y/Y)
Net cash used in
investing activities
-$117,541
(-102.75%↓ Y/Y)
Canceled cashflow
$150,074
Net loss
-$3,347,660
(43.81%↑ Y/Y)
Deferred patent costs
$77,488
(56.46%↑ Y/Y)
Purchases of property and
equipment
$40,053
(245.25%↑ Y/Y)
Operating lease liability
-$72,999
(52.65%↑ Y/Y)
Prepaid expenses
$16,636
(-84.59%↓ Y/Y)
Gain/loss on lease
modification
-$3,915
(-150.67%↓ Y/Y)
Buy us a coffee
Azitra, Inc. (AZTR)
Azitra, Inc. (AZTR)